Conditions & diseases

Alzheimer disease

Observed in 65 articles across 21 journals.

Falling

Latest share0.09%

Change vs baseline-0.13 pp

Months observed13

Latest monthJul 2026

Portfolio article share

Attention over this snapshot

13 monthly points

Journal breadth

Where it appears

Journal of Neurology, Neurosurgery & Psychiatry22
BMJ Open11
BMJ8
BMJ Neurology Open4
Practical Neurology3
Gut2
BMJ Evidence-Based Medicine1
BMJ Health & Care Informatics1
British Journal of Ophthalmology1
Drug and Therapeutics Bulletin1
European Journal of Hospital Pharmacy1
Evidence Based Nursing1

Co-occurrence

Explore nearby topics

Inspect the source signal

Article evidence

30 high-ranking examples

Journal of Neurology, Neurosurgery & Psychiatry · 2026-05-14

Cumulative cognitive benefits and brain volume change with anti-amyloid therapies for Alzheimer’s disease

Phrase rank #1 · DOI 10.1136/jnnp-2025-336691

BMJ · 2026-04-20

Advances in the drug treatment of Alzheimer’s disease: pathophysiology and mechanisms of action

Phrase rank #1 · DOI 10.1136/bmj-2023-078881

BMJ · 2026-02-11

New treatments for Alzheimer’s disease

Phrase rank #1 · DOI 10.1136/bmj.s273

Journal of Medical Genetics · 2026-01-20

No association of Alzheimer disease with the joint effect of HFE and TF in the mid-western Amish

Phrase rank #1 · DOI 10.1136/jmg-2025-111085

BMJ · 2026-01-09

Anti-amyloid antibodies for Alzheimer’s disease are not truly disease modifying

Phrase rank #1 · DOI 10.1136/bmj.s28

BMJ Open · 2026-01-06

What is the psychological and cognitive impact of returning Alzheimer disease dementia research results to healthy research participants? a delayed-start randomised clinical trial protocol for the WeSHARE study (Washington University study of having Alzheimer disease research results explained)

Phrase rank #1 · DOI 10.1136/bmjopen-2025-099970

Journal of Neurology, Neurosurgery & Psychiatry · 2025-11-26

73 Dynamic PET scanning in alzheimer’s disease- the old and the new

Phrase rank #1 · DOI 10.1136/jnnp-2025-ABN.73

BMJ Open · 2025-11-09

Effect of time-restricted feeding on cognitive dysfunction in Alzheimer’s disease and the role of ApoE polymorphism: protocol for a randomised controlled trial

Phrase rank #1 · DOI 10.1136/bmjopen-2025-099591

BMJ Open · 2025-10-20

Memory for Music (M4M) protocol for an international randomised controlled trial: effects of individual intensive musical training based on singing in non-musicians with Alzheimer’s disease

Phrase rank #1 · DOI 10.1136/bmjopen-2024-095136

BMJ · 2025-08-05

Evidence gap in blood biomarkers for Alzheimer’s disease

Phrase rank #1 · DOI 10.1136/bmj-2025-084781

Journal of Neurology, Neurosurgery & Psychiatry · 2026-06-12

Comparing amyloid immunotherapy with cholinesterase inhibitors for Alzheimer’s disease

Phrase rank #2 · DOI 10.1136/jnnp-2026-338722

Journal of Neurology, Neurosurgery & Psychiatry · 2026-06-12

Defining Alzheimer’s disease: stipulations and the ethics of diagnostic change

Phrase rank #2 · DOI 10.1136/jnnp-2025-337832

Journal of Neurology, Neurosurgery & Psychiatry · 2026-05-14

Accelerated long-term forgetting as a predictor of clinical onset in presymptomatic autosomal dominant Alzheimer’s disease

Phrase rank #2 · DOI 10.1136/jnnp-2025-336750

Journal of Neurology, Neurosurgery & Psychiatry · 2026-03-13

Risk of amyloid-related imaging abnormalities associated with anticoagulant therapy in patients with Alzheimer’s disease treated with anti-amyloid monoclonal antibodies: a systematic review and meta-analysis

Phrase rank #2 · DOI 10.1136/jnnp-2025-337386

Gut · 2026-01-08

Pathological tau propagation from the brain to the colon via the vagal efferent pathway in Alzheimer’s disease

Phrase rank #2 · DOI 10.1136/gutjnl-2024-334571

BMJ · 2026-01-08

Liraglutide for Alzheimer’s disease . . . and other research

Phrase rank #2 · DOI 10.1136/bmj.r2633

Journal of Neurology, Neurosurgery & Psychiatry · 2025-11-26

162 TRAILRUNNER-ALZ3: a phase-3 study of subcutaneous remternetug in preclinical and MCI Alzheimer’s disease population

Phrase rank #2 · DOI 10.1136/jnnp-2025-ABN.162

Journal of Neurology, Neurosurgery & Psychiatry · 2025-11-26

241 Relationships between inflammatory cytokines, neurodegenerative biomarkers, clinical progression and systemic infection in alzheimer’s disease

Phrase rank #2 · DOI 10.1136/jnnp-2025-ABN.241

Evidence Based Nursing · 2025-09-25

Preliminary evidence of an eye-tracking technique to detect Alzheimer’s disease in adults with Down syndrome

Phrase rank #2 · DOI 10.1136/ebnurs-2025-104323

BMJ Open · 2025-09-23

Evaluating care pathways in Alzheimer’s disease: a qualitative interview study with GPs in England

Phrase rank #2 · DOI 10.1136/bmjopen-2025-105978

BMJ Evidence-Based Medicine · 2025-09-22

Expanded disease definitions in Alzheimer’s disease and the new era of disease-modifying drugs

Phrase rank #2 · DOI 10.1136/bmjebm-2023-112588

BMJ Open · 2025-08-21

Epidemiology and risk factors of Alzheimer’s disease and related dementias in South and Southeast Asia: a systematic review and meta-analysis protocol

Phrase rank #2 · DOI 10.1136/bmjopen-2025-105955

Drug and Therapeutics Bulletin · 2025-07-31

Lecanemab (▼Leqembi) for Alzheimer’s disease

Phrase rank #2 · DOI 10.1136/dtb.2024.000057

BMJ Open · 2026-06-15

Association between the use of anti-herpetic drugs and subsequent initiation of Alzheimer’s disease drug treatment: Dutch population-based inception cohort study

Phrase rank #3 · DOI 10.1136/bmjopen-2025-114033

BMJ · 2026-04-30

Innovation in Alzheimer’s disease needs more than pharmaceutical solutions

Phrase rank #3 · DOI 10.1136/bmj.s788

Journal of Neurology, Neurosurgery & Psychiatry · 2025-11-26

112 Performance of alzheimer’s disease plasma biomarkers in prion diseases

Phrase rank #3 · DOI 10.1136/jnnp-2025-ABN.112

Journal of Neurology, Neurosurgery & Psychiatry · 2025-11-26

152 Repurposed drug prioritisation pipeline for an alzheimer’s disease multi-arm trial

Phrase rank #3 · DOI 10.1136/jnnp-2025-ABN.152

BMJ Open · 2025-11-21

Immune Profiling in Early Cognitive Disorders (IMPRINT) study protocol: a longitudinal cohort study exploring biomarkers of inflammation in early dementia with Lewy bodies and Alzheimer’s disease, as part of the Dementias Platform UK

Phrase rank #3 · DOI 10.1136/bmjopen-2025-107399

European Journal of Hospital Pharmacy · 2026-04-29

Drug repositioning in Alzheimer’s disease: a vascular perspective targeting the NO-cGMP pathway

Phrase rank #4 · DOI 10.1136/ejhpharm-2026-005089

Practical Neurology · 2026-03-13

Carphology

Phrase rank #4 · DOI 10.1136/pn-2026-005143